Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.

Joel WessendorfAlexander KönigHendrik HeersAndreas H Mahnken

Published in: Cardiovascular and interventional radiology (2021)

The results from this limited case series suggest that RFA of RCCs in patients with VHL is a safe and effective therapy, which can preserve sufficient renal function even after renal surgery.

Keyphrases

radiofrequency ablation
minimally invasive
single cell
bone marrow
atrial fibrillation
mesenchymal stem cells
ultrasound guided